{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["12(3)"],"submitter":["Comunale BA"],"pubmed_abstract":["<b>Introduction:</b> Prior research explores whether seasonal and childhood vaccines mitigate the risk of SARS-CoV-2 infection. Although there are trials investigating COVID-19 infection in response to the effects of the oral poliovirus vaccine (OPV), there has been no prior research assessing COVID-19 outcomes in recently immunized adults with the inactivated poliovirus vaccine (IPV). <b>Methods:</b> SARS-CoV-2 infection and COVID-19 symptoms were analyzed across a cohort of 282 adults who received an IPV booster. Bivariate and multivariate regression models explored associations among variables related to vaccination histories and COVID-19 outcomes. <b>Results:</b> One year post-IPV inoculation, participants who had never received OPV were more likely to test positive for SARS-CoV-2 and "],"journal":["Vaccines"],"pagination":["219"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10974902"],"repository":["biostudies-literature"],"pubmed_title":["Inactivated Poliovirus Vaccine Booster Reduces the Likelihood of COVID-19 Outcomes in Individuals Primed with Oral Poliovirus Vaccination."],"pmcid":["PMC10974902"],"pubmed_authors":["Hsu YJ","Larson RJ","Engineer LD","Azodoh C","Singh A","Jackson-Ward E","Comunale BA"],"additional_accession":[]},"is_claimable":false,"name":"Inactivated Poliovirus Vaccine Booster Reduces the Likelihood of COVID-19 Outcomes in Individuals Primed with Oral Poliovirus Vaccination.","description":"<b>Introduction:</b> Prior research explores whether seasonal and childhood vaccines mitigate the risk of SARS-CoV-2 infection. Although there are trials investigating COVID-19 infection in response to the effects of the oral poliovirus vaccine (OPV), there has been no prior research assessing COVID-19 outcomes in recently immunized adults with the inactivated poliovirus vaccine (IPV). <b>Methods:</b> SARS-CoV-2 infection and COVID-19 symptoms were analyzed across a cohort of 282 adults who received an IPV booster. Bivariate and multivariate regression models explored associations among variables related to vaccination histories and COVID-19 outcomes. <b>Results:</b> One year post-IPV inoculation, participants who had never received OPV were more likely to test positive for SARS-CoV-2 and ","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Feb","modification":"2026-04-08T15:24:05.429Z","creation":"2025-04-05T23:18:29.405Z"},"accession":"S-EPMC10974902","cross_references":{"pubmed":["38543853"],"doi":["10.3390/vaccines12030219"]}}